Free Trial

Orchestra BioMed (OBIO) Short Interest Ratio & Short Volume

Orchestra BioMed logo
$2.75 -0.22 (-7.41%)
Closing price 04:00 PM Eastern
Extended Trading
$2.81 +0.06 (+2.18%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Short Interest Data

Orchestra BioMed (OBIO) has a short interest of 541,400 shares, representing 2.03% of the float (the number of shares available for trading by the public). This marks a -5.40% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 153,803 shares to cover all short positions.

Current Short Interest
541,400 shares
Previous Short Interest
572,300 shares
Change Vs. Previous Month
-5.40%
Dollar Volume Sold Short
$1.53 million
Short Interest Ratio
1.9 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
38,313,000 shares
Float Size
26,640,000 shares
Short Percent of Float
2.03%
Today's Trading Volume
401,798 shares
Average Trading Volume
153,803 shares
Today's Volume Vs. Average
261%
Short Selling Orchestra BioMed?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Orchestra BioMed and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OBIO Short Interest Over Time

OBIO Days to Cover Over Time

OBIO Percentage of Float Shorted Over Time

Orchestra BioMed Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025541,400 shares $1.53 million -5.4%2.0%1.9 $2.82
3/31/2025572,300 shares $2.45 million +4.8%2.2%8.9 $4.28
3/15/2025546,200 shares $2.23 million +4.1%2.0%5.8 $4.08
2/28/2025524,800 shares $2.46 million +9.1%2.0%5.5 $4.69
2/15/2025480,900 shares $2.73 million +1.5%1.8%5.2 $5.67
1/31/2025474,000 shares $2.48 million -35.7%1.8%4.9 $5.24
1/15/2025736,700 shares $4.07 million +4.7%2.8%7.6 $5.52
12/31/2024703,900 shares $2.82 million +0.1%2.7%7.6 $4.00
12/15/2024703,200 shares $3.70 million -8.6%2.7%12.6 $5.26
11/30/2024769,700 shares $4.33 million +2.0%2.9%12.7 $5.63
11/15/2024754,300 shares $4.41 million -3.1%2.9%13.1 $5.84
10/31/2024778,600 shares $4.01 million -5.8%3.0%13.2 $5.15
10/15/2024826,100 shares $4.39 million -9.4%3.2%13.3 $5.32
9/30/2024911,900 shares $4.69 million -7.8%3.5%9.1 $5.14
9/15/2024989,000 shares $5.76 million -3.0%3.8%7.9 $5.82
8/31/20241,020,000 shares $6.83 million -3.8%3.9%8.3 $6.70
8/15/20241,060,000 shares $6.42 million +10.0%4.2%7.7 $6.06
7/31/2024963,600 shares $7.11 million -5.5%4.7%7.4 $7.38
7/15/20241,020,000 shares $8.70 million +24.2%5.0%8.2 $8.53
6/30/2024821,100 shares $6.69 million +7.0%4.0%9.8 $8.15
6/15/2024767,600 shares $6.12 million +0.6%3.7%12.7 $7.97
5/31/2024763,100 shares $5.29 million -8.5%3.7%13.3 $6.93
5/15/2024833,600 shares $4.01 million -2.7%4.1%21 $4.81
4/30/2024856,300 shares $3.78 million +2.8%3.9%19.6 $4.41
4/15/2024833,300 shares $4.03 million -2.9%3.8%17.6 $4.84
3/31/2024858,000 shares $4.52 million -2.1%4.1%16.5 $5.27
3/15/2024876,400 shares $4.52 million -2.7%4.2%15.7 $5.16
2/29/2024901,000 shares $5.80 million -8.7%4.3%14.7 $6.44
2/15/2024987,100 shares $6.89 million -6.0%4.7%16.1 $6.98
1/31/20241,050,000 shares $7.43 million +7.6%4.8%17.2 $7.08
1/15/2024976,100 shares $7.48 million -12.9%4.5%16.7 $7.66
12/31/20231,120,000 shares $10.23 million -5.9%5.1%17.6 $9.13
12/15/20231,190,000 shares $12.71 million +5.3%5.4%16.7 $10.68
11/30/20231,130,000 shares $7.03 million -13.1%5.2%8.3 $6.22
11/15/20231,300,000 shares $9.26 million +1.6%5.9%9.2 $7.12
10/31/20231,280,000 shares $6.00 million +4.1%5.8%8.5 $4.69
10/15/20231,230,000 shares $6.35 million +5.1%5.6%8 $5.16
9/30/20231,170,000 shares $10.20 million +76.3%5.3%8 $8.72
9/15/2023663,700 shares $4.68 million +3.3%3.0%4.7 $7.05
8/31/2023642,400 shares $4.01 million +5.6%2.9%7.5 $6.24
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
8/15/2023608,100 shares $3.43 million -5.8%2.8%7.1 $5.64
7/31/2023645,400 shares $3.79 million -7.2%2.9%8.2 $5.87
7/15/2023695,500 shares $5.24 million -1.0%3.0%9.3 $7.53
6/30/2023702,700 shares $4.92 million +91.9%3.0%9.4 $7.00
6/15/2023366,100 shares $3.99 million +76.3%1.6%4.8 $10.91
5/31/2023207,700 shares $3.12 million +9.8%1.0%3.2 $15.00
5/15/2023189,200 shares $3.30 million No Change0.9%3.2 $17.43

OBIO Short Interest - Frequently Asked Questions

What is Orchestra BioMed's current short interest?

Short interest is the volume of Orchestra BioMed shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 541,400 shares of OBIO short. 2.03% of Orchestra BioMed's shares are currently sold short. Learn More on Orchestra BioMed's current short interest.

What is a good short interest ratio for Orchestra BioMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OBIO shares currently have a short interest ratio of 2.0. Learn More on Orchestra BioMed's short interest ratio.

What is a good short interest percentage for Orchestra BioMed?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.03% of Orchestra BioMed's floating shares are currently sold short.

Is Orchestra BioMed's short interest increasing or decreasing?

Orchestra BioMed saw a drop in short interest in April. As of April 15th, there was short interest totaling 541,400 shares, a drop of 5.4% from the previous total of 572,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Orchestra BioMed's float size?

Orchestra BioMed currently has issued a total of 38,313,000 shares. Some of Orchestra BioMed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Orchestra BioMed currently has a public float of 26,640,000 shares.

How does Orchestra BioMed's short interest compare to its competitors?

2.03% of Orchestra BioMed's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Orchestra BioMed: Treace Medical Concepts, Inc. (4.97%), Delcath Systems, Inc. (3.96%), NeuroPace, Inc. (1.50%), ClearPoint Neuro, Inc. (3.47%), Tactile Systems Technology, Inc. (9.46%), Semler Scientific, Inc. (21.49%), Nano-X Imaging Ltd. (12.79%), Neuronetics, Inc. (12.57%), Sanara MedTech Inc. (6.05%), ZimVie Inc. (1.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Orchestra BioMed stock?

Short selling OBIO is an investing strategy that aims to generate trading profit from Orchestra BioMed as its price is falling. OBIO shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Orchestra BioMed?

A short squeeze for Orchestra BioMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OBIO, which in turn drives the price of the stock up even further.

How often is Orchestra BioMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OBIO, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:OBIO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners